Login
Cryoport, Inc. logo

Cryoport, Inc.

cryoport.com

What Do They Do?

Provides temperature-controlled transport, storage and cryopreservation services for life sciences customers, and sells cryogenic freezers and transport systems to biopharmaceutical companies, laboratories and research institutions.

How Do They Make Money?

Customers pay for storage and logistics support as those services are performed and for cryogenic equipment when it is delivered; invoices are generally due within 15 to 60 days. Shipper-use fees are earned when the shipper reaches the end user.

revenue
SegmentShareRevenue
BioLogistics Solutions
Sold outright

44%
FY2022: 53%
BioStorage/BioServices
Recurring

10%
FY2022: 3.8%
Product
Sold outright

45%
FY2022: 44%

Who Are Their Customers?

Biotechnology and pharmaceutical companies, research organizations and clinics buy its services directly; cryogenic systems go to life sciences customers through direct sales or distributors.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2023: no customer at 10% or more of revenue

Do Revenues Turn Into Profits?

Yes. It kept 44 cents of every revenue dollar as net income in FY2025, but spent more cash than it brought in: free cash flow was −$25M.

Operating income, FY2025
−21% of revenue
▲ +70% (Loss) vs FY2024 (−$121.7M, −78%)
Net income, FY2025
44% of revenue
▲ Turned profitable vs FY2024 (−$114.8M, −73%)
Free cash flow, FY2025
−14% of revenue
▲ +25% (Loss) vs FY2024 (−$33.6M, −21%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +14%
vs $44.2M in Q3 FY2025
Net income
▼ −56% (Loss)
vs −$6.9M in Q3 FY2025
Product share of revenue vs 45.2% in Q3 FY2025

Shrinking. Revenue fell 21% in 4 years, from $222.6M in FY2021 to $176.2M in FY2025, about 6% a year.

CRYOPDP divestiture The earlier report included CRYOPDP's courier operations in its global logistics offering; the latest report says Cryoport sold that business and describes its continuing operations without it.

Cryopreservation service rollout The earlier report described Cell Matters as the basis for a planned cryopreservation platform; the latest says IntegriCell services are offered and biopharma companies are being onboarded.

Revenue over time
BioLogistics Solutions BioStorage/BioServices Product Service
$250M$125M$0

Who Do They Compete With?

Competes with World Courier, UPS Healthcare, Quick, Biocair, American Red Cross, Gift of Life Biologics, Azenta Life Sciences, Phase 2, and IC Biomedical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support